{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:34:14Z","timestamp":1791815654864,"version":"4.3.4"},"reference-count":81,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG045390"],"award-info":[{"award-number":["AG045390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS092089"],"award-info":[{"award-number":["NS092089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG032306"],"award-info":[{"award-number":["AG032306"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG021886"],"award-info":[{"award-number":["AG021886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG016976"],"award-info":[{"award-number":["AG016976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG019724"],"award-info":[{"award-number":["AG019724"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG038791"],"award-info":[{"award-number":["AG038791"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG056749,"],"award-info":[{"award-number":["AG056749,"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG045333"],"award-info":[{"award-number":["AG045333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Alzheimer's &amp;amp; Dementia"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Familial frontotemporal lobar degeneration (f\u2010FTLD) due to autosomal dominant mutations is an important entity for developing treatments for FTLD. The Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) and Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) longitudinal studies were designed to describe the natural history of f\u2010FTLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We summarized recent publications from the ARTFL and LEFFTDS studies, along with other recent publications describing the natural history of f\u2010FTLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Published and emerging studies are producing data on all phases of f\u2010FTLD, including the asymptomatic and symptomatic phases of disease, as well as the transitional phase when symptoms are just beginning to develop. These data indicate that rates of change increase along with disease severity, which is consistent with commonly cited models of neurodegeneration, and that measurement of biomarkers may predict onset of symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Data from large multisite studies are producing important data on the natural history of f\u2010FTLD that will be critical for planning intervention trials.<\/jats:p><\/jats:sec>","DOI":"10.1002\/alz.12004","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T10:19:58Z","timestamp":1579169998000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS"],"prefix":"10.1002","volume":"16","author":[{"given":"Howard J.","family":"Rosen","sequence":"first","affiliation":[{"name":"Department of Neurology Memory and Aging Center University of California, San Francisco  San Francisco California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[{"name":"Department of Neurology Mayo Clinic  Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[{"name":"Department of Neurology Memory and Aging Center University of California, San Francisco  San Francisco California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","article-title":"Frontotemporal dementia","volume":"386","author":"Bang J","year":"2015","journal-title":"Lancet"},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrneurol.2012.117","article-title":"Advances in understanding the molecular basis of frontotemporal dementia","volume":"8","author":"Rademakers R","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.58.11.1615","article-title":"The prevalence of frontotemporal dementia","volume":"58","author":"Ratnavalli E","year":"2002","journal-title":"Neurology"},{"key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/brain\/awg204","article-title":"Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population\u2010based study","volume":"126","author":"Rosso SM","year":"2003","journal-title":"Brain"},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/01.WNL.0000106827.39764.7E","article-title":"The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994","volume":"62","author":"Knopman DS","year":"2004","journal-title":"Neurology"},{"key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/09540261.2013.776523","article-title":"The epidemiology of frontotemporal dementia","volume":"25","author":"Onyike CU","year":"2013","journal-title":"Int Rev Psychiatry"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","article-title":"Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes","volume":"86","author":"Coyle\u2010Gilchrist IT","year":"2016","journal-title":"Neurology"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/01.wnl.0000173837.82820.9f","article-title":"Frontotemporal dementia progresses to death faster than Alzheimer disease","volume":"65","author":"Roberson ED","year":"2005","journal-title":"Neurology"},{"key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/WAD.0b013e31819e6b28","article-title":"Frequency and causes of early\u2010onset dementia in a tertiary referral center in Athens","volume":"23","author":"Papageorgiou SG","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000080123","article-title":"Frontotemporal dementia: behavioral symptoms and caregiver distress","volume":"18","author":"Mourik JC","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/17482961003605788","article-title":"Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis","volume":"11","author":"Merrilees J","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0000000000004614","article-title":"The social and economic burden of frontotemporal degeneration","volume":"89","author":"Galvin JE","year":"2017","journal-title":"Neurology"},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(12)70320-4","article-title":"Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double\u2010blind, placebo\u2010controlled trial","volume":"12","author":"Boxer AL","year":"2013","journal-title":"Lancet Neurol"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jalz.2012.03.002","article-title":"Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development","volume":"9","author":"Boxer AL","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"1","key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jnc.13640","article-title":"Therapy and clinical trials in frontotemporal dementia: past, present, and future","volume":"138","author":"Tsai RM","year":"2016","journal-title":"J Neurochem"},{"key":"e_1_2_11_17_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12035-014-8724-7","article-title":"Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS\/FTD diseases","volume":"50","author":"Riboldi G","year":"2014","journal-title":"Mol Neurobiol"},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.trci.2017.08.002","article-title":"An 8\u2010week, open\u2010label, dose\u2010finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations","volume":"3","author":"Sha SJ","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"e_1_2_11_19_1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1212\/WNL.0000000000001133","article-title":"Oxytocin for frontotemporal dementia: a randomized dose\u2010finding study of safety and tolerability","volume":"84","author":"Finger EC","year":"2015","journal-title":"Neurology"},{"key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awx198","article-title":"Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease","volume":"140","author":"Chitramuthu BP","year":"2017","journal-title":"Brain"},{"key":"e_1_2_11_21_1","first-page":"236","article-title":"Preclinical and clinical development of ABBV\u20108E12, a humanized anti\u2010tau antibody, for treatment of alzheimer's disease and other tauopathies","volume":"4","author":"West T","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_2_11_22_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrd.2017.37","article-title":"Alzheimer disease: antisense oligonucleotide reverses tau pathology","volume":"16","author":"Crunkhorn S","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"pii: eaal2029","DOI":"10.1126\/scitranslmed.aal2029","article-title":"Anti\u2010tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy","volume":"9","author":"Yanamandra K","year":"2017","journal-title":"Sci Transl Med"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5'\u2010splice\u2010site mutations in tau with the inherited dementia FTDP\u201017","volume":"393","author":"Hutton M","year":"1998","journal-title":"Nature"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau\u2010negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker M","year":"2006","journal-title":"Nature"},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p\u2010linked FTD and ALS","volume":"72","author":"DeJesus\u2010Hernandez M","year":"2011","journal-title":"Neuron"},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21\u2010linked ALS\u2010FTD","volume":"72","author":"Renton AE","year":"2011","journal-title":"Neuron"},{"key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0072-9752(07)01232-8","article-title":"Epidemiological aspects of frontotemporal dementia","volume":"89","author":"Swieten JC","year":"2008","journal-title":"Handb Clin Neurol"},{"key":"e_1_2_11_29_1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1212\/WNL.0b013e3181bf997a","article-title":"The heritability and genetics of frontotemporal lobar degeneration","volume":"73","author":"Rohrer JD","year":"2009","journal-title":"Neurology"},{"key":"e_1_2_11_30_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1212\/WNL.0000000000006088","article-title":"How early can we diagnose Alzheimer disease (and is it sufficient)? The 2017 Wartenberg lecture","volume":"91","author":"Petersen RC","year":"2018","journal-title":"Neurology"},{"key":"e_1_2_11_31_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mcn.2018.12.004","article-title":"Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease","volume":"97","author":"Cohen AD","year":"2019","journal-title":"Mol Cell Neurosci"},{"key":"e_1_2_11_32_1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/WNL.0000000000003907","article-title":"Randomized controlled trials in mild cognitive impairment: sources of variability","volume":"88","author":"Petersen RC","year":"2017","journal-title":"Neurology"},{"key":"e_1_2_11_33_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack CR","year":"2013","journal-title":"Lancet Neurol"},{"key":"e_1_2_11_34_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neurol.2013.07.017","article-title":"Preclinical trials in autosomal dominant AD: implementation of the DIAN\u2010TU trial","volume":"169","author":"Mills SM","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_2_11_35_1","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling RA","year":"2014","journal-title":"Sci Transl Med"},{"key":"e_1_2_11_36_1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"The mild behavioral impairment checklist (MBI\u2010C): a rating scale for neuropsychiatric symptoms in pre\u2010dementia populations","volume":"56","author":"Ismail Z","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"e_1_2_11_37_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/WNL.0000000000000733","article-title":"Recommendations of the Alzheimer's disease\u2010related dementias conference","volume":"83","author":"Montine TJ","year":"2014","journal-title":"Neurology"},{"key":"e_1_2_11_38_1","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1212\/WNL.0000000000004717","article-title":"Alzheimer's Disease\u2010Related Dementias Summit 2016: national research priorities","volume":"89","author":"Corriveau RA","year":"2017","journal-title":"Neurology"},{"key":"e_1_2_11_39_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(14)70324-2","article-title":"Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal Dementia Initiative (GENFI) study: a cross\u2010sectional analysis","volume":"14","author":"Rohrer JD","year":"2015","journal-title":"Lancet Neurol"},{"key":"e_1_2_11_40_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/01.wnl.0000171343.43314.6e","article-title":"Rate of progression differs in frontotemporal dementia and Alzheimer disease","volume":"65","author":"Rascovsky K","year":"2005","journal-title":"Neurology"},{"key":"e_1_2_11_41_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/WAD.0b013e3181a6f101","article-title":"Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease","volume":"24","author":"Krueger CE","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"e_1_2_11_42_1","article-title":"Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F\u2010FDG\u2010PET\u2010study","author":"Diehl\u2010Schmid J","year":"2006","journal-title":"Neurobiol Aging"},{"key":"e_1_2_11_43_1","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awn234","article-title":"Development of methodology for conducting clinical trials in frontotemporal lobar degeneration","volume":"131","author":"Knopman DS","year":"2008","journal-title":"Brain"},{"key":"e_1_2_11_44_1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.0b013e3181a71236","article-title":"Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year","volume":"72","author":"Knopman DS","year":"2009","journal-title":"Neurology"},{"key":"e_1_2_11_45_1","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.neuroimage.2007.10.001","article-title":"Rates of brain atrophy over time in autopsy\u2010proven frontotemporal dementia and Alzheimer disease","volume":"39","author":"Whitwell JL","year":"2008","journal-title":"Neuroimage"},{"key":"e_1_2_11_46_1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/WNL.0b013e3181d1a879","article-title":"Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study","volume":"74","author":"Gordon E","year":"2010","journal-title":"Neurology"},{"key":"e_1_2_11_47_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ana.24296","article-title":"Longitudinal diffusion tensor imaging in frontotemporal dementia","volume":"77","author":"Mahoney CJ","year":"2015","journal-title":"Ann Neurol"},{"key":"e_1_2_11_48_1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/brain\/awy319","article-title":"Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials","volume":"142","author":"Staffaroni AM","year":"2019","journal-title":"Brain"},{"key":"e_1_2_11_49_1","doi-asserted-by":"crossref","first-page":"e00675","DOI":"10.1002\/brb3.675","article-title":"Data\u2010driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration","volume":"7","author":"Binney RJ","year":"2017","journal-title":"Brain Behav"},{"key":"e_1_2_11_50_1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.0b013e318227047f","article-title":"Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN","volume":"77","author":"Whitwell JL","year":"2011","journal-title":"Neurology"},{"key":"e_1_2_11_51_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/alzrt144","article-title":"Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions","volume":"4","author":"Mahoney CJ","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"e_1_2_11_52_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ene.12675","article-title":"Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images","volume":"22","author":"Whitwell JL","year":"2015","journal-title":"Eur J Neurol"},{"key":"e_1_2_11_53_1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.nicl.2016.10.014","article-title":"Longitudinal imaging in C9orf72 mutation carriers: relationship to phenotype","volume":"12","author":"Floeter MK","year":"2016","journal-title":"Neuroimage Clin"},{"key":"e_1_2_11_54_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jnnp-2017-316799","article-title":"Longitudinal diffusion imaging across the C9orf72 clinical spectrum","volume":"89","author":"Floeter MK","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_11_55_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.24052","article-title":"Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration","volume":"75","author":"Scherling CS","year":"2014","journal-title":"Ann Neurol"},{"key":"e_1_2_11_56_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neubiorev.2019.04.014","article-title":"Neurofilament light chain protein in neurodegenerative dementia: a systematic review and network meta\u2010analysis","volume":"102","author":"Zhao Y","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"e_1_2_11_57_1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/acn3.643","article-title":"Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory","volume":"5","author":"Ljubenkov PA","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_11_58_1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer JD","year":"2016","journal-title":"Neurology"},{"key":"e_1_2_11_59_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/acn3.290","article-title":"Plasma neurofilament light chain predicts progression in progressive supranuclear palsy","volume":"3","author":"Rojas JC","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_11_60_1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","volume":"3","author":"Meeter LH","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_11_61_1","first-page":"1","article-title":"NIH EXAMINER: conceptualization and development of an executive function battery","author":"Kramer JH","year":"2013","journal-title":"J Int Neuropsychol Soc"},{"key":"e_1_2_11_62_1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.0000000000002895","article-title":"Presymptomatic cognitive decline in familial frontotemporal dementia: a longitudinal study","volume":"87","author":"Jiskoot LC","year":"2016","journal-title":"Neurology"},{"key":"e_1_2_11_63_1","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1212\/WNL.0000000000000583","article-title":"Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia","volume":"83","author":"Dopper EG","year":"2014","journal-title":"Neurology"},{"key":"e_1_2_11_64_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nicl.2018.05.017","article-title":"Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers","volume":"19","author":"Olm CA","year":"2018","journal-title":"Neuroimage Clin"},{"key":"e_1_2_11_65_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2018.12.017","article-title":"Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study","volume":"76","author":"Panman JL","year":"2019","journal-title":"Neurobiol Aging"},{"key":"e_1_2_11_66_1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","article-title":"Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers","volume":"14","author":"Lee SE","year":"2017","journal-title":"Neuroimage Clin"},{"key":"e_1_2_11_67_1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.nicl.2016.08.001","article-title":"Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: a longitudinal arterial spin labeling study","volume":"12","author":"Dopper EG","year":"2016","journal-title":"Neuroimage Clin"},{"key":"e_1_2_11_68_1","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.0b013e3182a8237e","article-title":"Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers","volume":"81","author":"Jacova C","year":"2013","journal-title":"Neurology"},{"issue":"8","key":"e_1_2_11_69_1","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1212\/WNL.0000000000007961","article-title":"Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers","volume":"93","author":"Chen Q","year":"2019","journal-title":"Neurology"},{"key":"e_1_2_11_70_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","article-title":"CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion","volume":"78","author":"Lee JM","year":"2012","journal-title":"Neurology"},{"key":"e_1_2_11_71_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/CON.0000000000000687","article-title":"Early\u2010onset Alzheimer disease and its variants","volume":"25","author":"Mendez MF","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"issue":"8","key":"e_1_2_11_72_1","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves CV","year":"2019","journal-title":"J Neurol"},{"key":"e_1_2_11_73_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris JC","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"e_1_2_11_74_1","article-title":"Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration","author":"Staffaroni AM","year":"2019","journal-title":"Alzheimers Dement"},{"key":"e_1_2_11_75_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/brain\/awy288","article-title":"Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia","volume":"142","author":"Jiskoot LC","year":"2019","journal-title":"Brain"},{"issue":"11","key":"e_1_2_11_76_1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/jnnp-2019-320774","article-title":"A multimodal MRI\u2010based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers","volume":"90","author":"Feis RA","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_11_77_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2019.08.011","article-title":"LEFFTDS Consortium Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers","volume":"83","author":"Chen Q","year":"2019","journal-title":"Neurobiol Aging"},{"issue":"5","key":"e_1_2_11_78_1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jon.12642","article-title":"Brain MR spectroscopy changes precede frontotemporal lobar degeneration phenoconversion in mapt mutation carriers","volume":"29","author":"Chen Q","year":"2019","journal-title":"J Neuroimaging"},{"key":"e_1_2_11_79_1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2011-301883","article-title":"Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion","volume":"83","author":"Khan BK","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_11_80_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/13554794.2018.1428353","article-title":"Slowly progressive behavioral frontotemporal dementia with C9orf72 mutation. Case report and review of the literature","volume":"24","author":"Llamas\u2010Velasco S","year":"2018","journal-title":"Neurocase"},{"key":"e_1_2_11_81_1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische O","year":"2019","journal-title":"Nat Med"},{"key":"e_1_2_11_82_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/brain\/awy314","article-title":"Multimodal imaging in familial FTLD: phenoconversion and planning for the future","volume":"142","author":"Boeve BF","year":"2019","journal-title":"Brain"}],"container-title":["Alzheimer's &amp; Dementia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Falz.12004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alz.12004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/alz.12004","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/alz.12004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T20:38:36Z","timestamp":1759869516000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/alz.12004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1002\/alz.12004"],"URL":"https:\/\/doi.org\/10.1002\/alz.12004","archive":["Portico"],"relation":{},"ISSN":["1552-5260","1552-5279"],"issn-type":[{"value":"1552-5260","type":"print"},{"value":"1552-5279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"2019-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}